Related Experiment Video
Updated: May 18, 2026
06:19
Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease
Published on: October 20, 2023
IDH1 mutations disrupt blood, brain, and barriers
1Human Oncology and Pathogenesis Program, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cancer Cell
|September 15, 2012
Summary
Two new mouse models reveal how IDH1(R132H) mutations drive cancer. These models show epigenetic changes in blood cells and microenvironment alterations in the brain, offering insights into tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The isocitrate dehydrogenase 1 (IDH1) R132H mutation is a key driver in various cancers, including gliomas and acute myeloid leukemia.
- Understanding the precise mechanisms of IDH1(R132H)-driven transformation is crucial for developing targeted therapies.
Purpose of the Study:
- To establish and characterize the first two murine models specifically harboring the IDH1(R132H) mutation.
- To elucidate the mechanistic pathways involved in cellular transformation induced by the IDH1(R132H) mutation in different tissue contexts.
Main Methods:
- Development of genetically engineered mouse models expressing the IDH1(R132H) mutation.
- Analysis of epigenetic alterations in hematopoietic cells, including TET2 and histone demethylase activity.
- Investigation of the central nervous system microenvironment, focusing on collagen and prolyl hydroxylase inhibition.
Main Results:
- In hematopoietic cells, IDH1(R132H) leads to epigenetic dysregulation, resulting in the accumulation of precursor cells.
- In the central nervous system, IDH1(R132H) causes alterations in the tumor microenvironment and impairs angiogenesis.
Conclusions:
- The established murine models provide valuable tools for studying IDH1(R132H) oncogenesis.
- IDH1(R132H) mutation impacts distinct cellular pathways in different tissues, contributing to tumor initiation and progression.
Related Concept Videos
00:49The Blood-brain Barrier
Overview
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...